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Antigen recognition by the T-cell receptor (TCR) is a hallmark of
the adaptive immune system. When the TCR engages a peptide
bound to the restricting major histocompatibility complex mole-
cule (pMHC), it transmits a signal via the associated CD3 complex.
How the extracellular antigen recognition event leads to intracel-
lular phosphorylation remains unclear. Here, we used single-
molecule localization microscopy to quantify the organization of
TCR–CD3 complexes into nanoscale clusters and to distinguish be-
tween triggered and nontriggered TCR–CD3 complexes. We found
that only TCR–CD3 complexes in dense clusters were phosphory-
lated and associated with downstream signaling proteins, demon-
strating that the molecular density within clusters dictates signal
initiation. Moreover, both pMHC dose and TCR–pMHC affinity de-
termined the density of TCR–CD3 clusters, which scaled with over-
all phosphorylation levels. Thus, TCR–CD3 clustering translates
antigen recognition by the TCR into signal initiation by the CD3
complex, and the formation of dense signaling-competent clusters
is a process of antigen discrimination.
TCR triggering | signal transduction | single-molecule localization
microscopy
The activation of T cells orchestrates an adaptive immuneresponse by translating antigen binding to the T-cell receptor
(TCR) into appropriate cellular responses (1–4). The αβ TCR
engages MHC molecules (or HLA) bound to antigenic peptides
(pMHC) on the surface of antigen-presenting cells (5). The in-
teraction of the TCR with pMHC is highly specific because T
cells are able to distinguish rare foreign pMHC among abundant
self pMHC molecules (6). TCR signaling is also extremely sen-
sitive; even a single pMHC molecule is sufficient to trigger ac-
tivation (7–9). TCRs are noncovalently coupled to the conserved
multisubunit CD3 complex, comprising CD3eγ, CD3eδ, and CD3ζζ
dimers (10), whose immunoreceptor tyrosine-based activation mo-
tifs (ITAMs) are phosphorylated upon pMHC engagement by the
nonreceptor tyrosine kinase Lck (1, 2). ITAM phosphorylation is
required for the recruitment and phosphorylation of the ζ-chain-
associated protein kinase 70 kDa (Zap70) and the adaptor linker
for activation of T cells (Lat) (11) to mediate downstream activa-
tion responses (12). Phosphorylation of the TCR–CD3 complex is
one of the earliest detectable biochemical events in T-cell signaling
and already at this level, important “activation decisions” are being
made. For example, when the extent of ITAM phosphorylation was
modulated through specific mutations, low levels of TCR–CD3
phosphorylation were sufficient for signaling through the Zap70–
SLP-76–Lat pathway and cytokine production, whereas high levels
of TCR–CD3 phosphorylation were required for Vav1-Numb-
Notch signaling and T-cell proliferation (12–14). However, how
the TCR–CD3 complex encodes both the quality and quantity of
pMHC molecules and steers signaling activities toward appro-
priate cellular outcomes is not fully understood (1–4).
Although many of the molecular players and TCR signaling
pathways have been identified and characterized by biochemical
and genetic approaches (12, 15), the precise mechanism by which
the binding of the TCR to pMHC results in phosphorylation of
the TCR–CD3 complex, referred to as TCR triggering, still re-
mains contested (1, 16). There is increasing evidence that the
spatial reorganization of the TCR into micrometer- and sub-
micron-sized clusters is involved in regulating T-cell activation (2,
11, 17–19). With the advent of superresolution fluorescence mi-
croscopy, we have gained a much more nuanced picture of the
spatial organization of TCR signaling proteins (3, 20). In partic-
ular, single-molecule localization microscopy [SMLM, including
photoactivated localization microscopy (PALM) (21) and direct
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stochastic optical reconstruction microscopy (dSTORM) (22)]
was used to report that at least a proportion of TCRs were or-
ganized into small clusters that were 30–300 nm in diameter,
termed “nanoclusters” (23, 24). Similarly, Lat (23–25), Lck (26),
and Zap70 (24, 27) were also found to reside in nanoclusters that
are extensively remodeled during T-cell activation. The link be-
tween preexisting and pMHC-induced nanoclustering and sig-
naling activities is not clear at present and is the focus of the
present study.
To identify the functional role of TCR nanoclusters, we used
two-color SMLM data and integrated a cluster detection method,
density-based spatial clustering of applications with noise (DBSCAN)
(28) with a customized colocalization analysis (29). This process
allowed us to distinguish phosphorylated from nonphosphorylated
TCR–CD3 complex clusters in intact T cells and identify the spatial
organization at which individual TCR–CD3 complexes had the
highest signaling efficiency. We found that not all TCR–CD3
complexes had the same likelihood of being phosphorylated, even
with excess doses of high-affinity pMHC molecules. The signaling
efficiency of the TCR–CD3 complex was dependent upon the
distance to neighboring complexes so that dense nanoclusters had
the highest TCR triggering efficiency.
Results
CD3ζ Molecules Exist in Nanoclusters That Increase in Molecular
Density upon T-Cell Activation. To directly link antigen recogni-
tion to signal initiation, we aimed to establish single-molecule
maps that contained both the spatial organization and the sig-
naling (i.e., phosphorylation) status of the TCR–CD3 complex.
Because CD3ζ faithfully reports the localization of the TCR–CD3
complex (30), we fused CD3ζ to the photoactivatable fluorescent
protein PSCFP2 and expressed the CD3 dimers in conjunction
with three different MHC class I (MHC-I) –restricted αβ TCRs:
(i) the human ILA1 TCR that recognizes the HLA-A2–restricted
peptide ILAKFLHWL (ILA) (31); (ii) the human 1G4 TCR
that recognizes the HLA-A2–restricted peptide SLLMWITQC
(32); and (iii) the mouse OT-I TCR that recognizes the H-2Kb-
restricted peptide SIINFEKL (OVA) (33). We used Jurkat cells
transduced to express OT-I (Jurkat–OT-I) and ILA1 (Jurkat–
ILA1) and CRISPR/Cas9 gene-edited Jurkat cells expressing 1G4
(deficient in endogenous CD3ζ expression; Jurkat–1G4), as well
as primary mouse OT-I CD8+ T cells. Cells were imaged by PALM
after stimulation on two types of surfaces: (i) glass coverslips
coated either with poly-L-lysine (PLL, nonactivating) or with
anti-CD3e and anti-CD28 antibodies (αCD3+αCD28, activating)
(Fig. 1A); and (ii) supported lipid bilayers containing either in-
tercellular adhesion molecule 1 (ICAM-1, nonactivating) or ICAM-
1 and pMHC-I molecules (activating) (Fig. 1A). Whereas immo-
bilized antibodies trigger the TCR and induce early T-cell signaling,
including phosphorylation of CD3ζ (pCD3ζ) (Fig. 1B), T cells on
laterally mobile bilayers form a spatial arrangement, known as the
immunological synapse (11, 26, 34), where the TCR–CD3 complex
accumulates in the central region (Fig. 1A). Phosphorylated CD3ζ
(pCD3ζ) was stained with phospho-specific antibodies and imaged
by dSTORM (22, 35). Both CD3ζ–PSCFP2 and immunostained
pCD3ζ could be localized with <30-nm positional accuracy (SI
Appendix, Fig. S1 A and B).
A global distribution analysis based on Ripley’s K-function (26,
36) (SI Appendix, Fig. S1 C and D) revealed that CD3ζ–PSCFP2
was less randomly distributed in activated T cells compared with
resting T cells, independent of antibody versus pMHC-I stimula-
tion (SI Appendix, Fig. S2), confirming previous findings (23, 26).
To identify nanoscale clusters within an image, we implemented
a cluster detection analysis called DBSCAN (28), which links
only closely packed points together in a propagative manner (SI
Appendix, Fig. S3 A and B). We could thus identify molecules
within and outside clusters with diameters of 84 ± 9 nm (αCD3+
αCD28) and 102 ± 20 nm (ICAM-1 + OVA) (Fig. 1A). Antibody
and pMHC-I stimulation had different effects for different TCRs
with respect to percentage of molecules in clusters, cluster area,
number of clusters per area, and cluster shape (SI Appendix, Figs.
S3 C—H and S4). However, there was one cluster parameter that
was consistent across different TCRs, namely the molecular den-
sity within clusters, which was always significantly higher in acti-
vated versus resting T cells irrespective of antibody versus pMHC-
I conditions (Fig. 1C and SI Appendix, Fig. S5). In addition, we
found that the longer the stimulation, the denser the CD3ζ clus-
ters became, both for antibody and pMHC stimulation (SI Ap-
pendix, Fig. S6). Noticeably, pCD3ζ was visibly more clustered
than CD3ζ (Fig. 1B), which was also reflected in a higher per-
centage of pCD3ζ molecules in clusters and a higher molecular
density of pCD3ζ vs. CD3ζ clusters (SI Appendix, Fig. S7). This
was not an artifact caused by different photophysical properties
of the fluorophores, because pCD3ζ clusters were denser than
Fig. 1. TCR activation-induced CD3ζ clustering. (A, Top) Single-molecule
images of CD3ζ–PSCFP2 in Jurkat–OT-I cells on resting (PLL-coated) or anti-
body-coated (anti-CD3e and anti-CD28 antibodies, αCD3+αCD28) glass surfaces
(Left, 10 min) and on supported lipid bilayers (Right, 15 min) containing ICAM-
1 only (500 molecules/μm2) or ICAM-1 and OVA–MHC-I (200 molecules/μm2).
(Scale bars, 10 μm.) (Middle) Molecular density maps from representative
regions (4 μm × 4 μm) highlighted in the single-molecule images (red boxes);
normalized relative density is pseudocolored according to the depicted scale.
(Bottom) Zoomed cluster maps (1.5 μm × 1.5 μm) corresponding to red boxes
in the Middle row. CD3ζ molecules in clusters are colored green and mole-
cules outside clusters are in blue. Cluster contours are highlighted with red
lines. (B) Cluster maps of representative CD3ζ and pCD3ζ image regions
(4 μm × 4 μm) in Jurkat–OT-I cells on activating surfaces as in A. (C) Relative
density in clusters of CD3ζ (ratio of molecular density of CD3ζ inside clusters to
total molecular density) for the conditions presented in A. Data are mean ±
SEM from 7 to 20 regions from 4 to 6 cells per condition; **P < 0.01 and ***P <
0.001 (unpaired t test).



























TCR–CD3 clusters, even when imaged with the same fluorophore,
Alexa Fluor647 (SI Appendix, Fig. S7D). Together, these findings
suggest a correlation between CD3ζ clustering and CD3ζ
phosphorylation.
The Density of CD3ζ Molecules in Clusters Determines Triggering
Efficiency. To identify triggered and nontriggered TCR–CD3
complexes within a single-molecule image, we conducted two-
color SMLM imaging (Fig. 2A) and developed an analysis strategy
that combines cluster detection and colocalization analysis. The
degree-of-colocalization (DoC) analysis (29) determines the local
density for each molecule at increasing radii, providing a density
gradient for each channel (Fig. 2B). The analysis correlates the
two density gradients and assigns a DoC score to each molecule,
with −1 being anticorrelated (i.e., the two proteins are segregated),
0 meaning no correlation, and +1 being correlated (i.e., the two
proteins are colocalized). We verified that the DoC analysis is: (i)
insensitive to total or relative expression level in either channel;
(ii) insensitive to whether colocalized molecules are randomly
distributed or clustered; and (iii) unaffected by “undetected”
molecules (SI Appendix, Figs. S8 and S9). When applied to CD3ζ
molecules to analyze colocalization with pCD3ζ, this approach
allows us to discriminate triggered from nontriggered TCR–CD3
complexes. In T cells stimulated on bilayers with physiological
concentrations of pMHC-I (400 molecules/μm2) (Fig. 2C), the
majority of CD3ζ molecules had a low DoC score. We defined a
DoC score threshold of ≥0.4 for colocalization (SI Appendix, Fig.
S10) and found that only ∼23% of all CD3ζ molecules were
colocalized with pCD3ζ (i.e., triggered). Because we retained the
spatial information, we could determine the average DoC score for
clustered and nonclustered molecules (Fig. 2D). Although ∼20%
of total CD3ζ molecules resided outside clusters, only 12.5% of
these nonclustered CD3ζ molecules had a DoC score ≥0.4 (SI
Appendix, Fig. S11A), strongly indicating a low triggering efficiency
for nonclustered molecules. These triggered nonclustered mole-
cules represent only 18% of all triggered CD3ζ molecules (Fig.
2F), whereas the majority (∼80%) of triggered CD3ζ molecules
(Fig. 2F) resided in clusters that contained 30% of all CD3ζ
molecules (Fig. 2E). This finding is consistent with the overall
higher degree of clustering of pCD3ζ (Fig. 1B and SI Appendix,
Fig. S7).
Closer inspection of the TCR triggering maps (Fig. 2C)
revealed that some clusters contained predominantly triggered
CD3ζmolecules, whereas others contained only nontriggered CD3ζ
molecules. To distinguish these two types of clusters, we defined
“triggered CD3ζ clusters” as containing ≥10 CD3ζ molecules
that have a DoC score ≥0.4 (i.e., containing ≥10 triggered CD3ζ
molecules per cluster). This definition was justified because it
meant that triggered CD3ζ clusters contained close to 80% of all
triggered CD3 molecules, whereas nontriggered clusters contained
<5% (Fig. 2F). The most striking difference between triggered
and nontriggered clusters was the molecular density within clus-
ters; triggered clusters were ∼twofold denser than nontriggered
clusters (Fig. 2G). This was true for all three TCRs as well as
for antibody and pMHC-I activation, thereby indicating generality
in our observations (SI Appendix, Fig. S11B). Importantly, we
confirmed that the presence of endogenous, unlabeled CD3ζ
did not bias the analysis, because we obtained the same results
Fig. 2. TCR triggering occurs in dense clusters. (A) Two-color single-molecule images of CD3ζ–PSCFP2 (Left) and pCD3ζ–Dylight649 (Right) in a Jurkat-ILA1 cell
stimulated (15 min) on a lipid bilayer presenting ICAM-1 (500 molecules/μm2) and high-affinity 3G–MHC-I (400 molecules/μm2). (Scale bar, 10 μm.) (B) DoC
analysis. From the molecular coordinates of CD3ζ and pCD3ζ, the local density of each channel is calculated at increasing radius sizes around each molecule,
providing density gradients for both channels. The two gradients of density are tested for correlation, resulting in a DoC score for each molecule. DoC scores
range from −1 to +1, with −1 indicating segregation, 0 indicating random distribution, and +1 indicating colocalization. (C) Cluster map (Left) of CD3ζ (green)
and pCD3ζ (red), and corresponding pseudocolored DoC map (Right), for CD3ζ molecules in the highlighted region in A (red box, 4 μm × 4 μm). Black dots in
the cluster map represent nonclustered molecules. Below are shown enlarged nontriggered and triggered CD3ζ clusters with molecules color-coded according
to their DoC scores. (D) Average DoC score of CD3ζ molecules outside clusters, in nontriggered clusters and in triggered clusters. (E) Distribution of total CD3ζ
molecules between nonclustered molecules, molecules in nontriggered clusters, and molecules in triggered clusters. (F) Distribution of triggered CD3ζ
molecules between nonclustered molecules, molecules in nontriggered clusters and molecules in triggered clusters. (G) Relative density of CD3ζ molecules in
triggered and nontriggered clusters. (H) The percentage of CD3ζmolecules that are triggered in nondense and dense clusters. Clusters were classified as dense
or nondense based on the density threshold defined in SI Appendix, Fig. S12. In D–H, data are mean ± SEM from 10 regions from 5 cells. In D–F, **P < 0.01 and
****P < 0.0001 (one-way ANOVA). In G and H, *P < 0.05 and ****P < 0.0001 (paired t test).
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with Jurkat–1G4 cells that lack endogenous, unlabeled CD3ζ
(SI Appendix, Figs. S2C, S4C, S5 A and B, S7A, and S11B). For
antigen-stimulated Jurkat–ILA1 cells, nontriggered clusters had
an average of 3 CD3ζ molecules and a diameter of ∼54 nm,
corresponding to an average CD3ζ-to-CD3ζ spacing of ∼17 nm
(3,500 molecules/μm2), whereas triggered clusters had 55 CD3ζ
molecules and a diameter of ∼185 nm, with an average spacing of
∼10 nm (9,500 molecules/μm2) (SI Appendix, Fig. S11C).
Given that pMHC-I engagement and antibody stimulation
induced the formation of dense TCR–CD3 clusters (Fig. 1C) and
triggered CD3ζ resided predominantly in dense clusters (Fig. 2 F
and G), it was also possible to group clusters according to their
density (SI Appendix, Fig. S12) and demonstrate that dense
clusters had a higher TCR triggering efficiency (Fig. 2H). Al-
though only ∼30% of CD3ζ resided in dense clusters (SI Ap-
pendix, Fig. S12B), these molecules constituted the majority of
triggered CD3ζ molecules.
TCR Engagement Leads to Receptor Clustering Independently of
Phosphorylation. Although the data show that denser TCR–CD3
clusters have a higher probability of being triggered, it is still un-
clear whether tighter clustering leads to increased phosphorylation
of CD3ζ or whether phosphorylated TCR–CD3 molecules pref-
erentially associate into dense clusters. To investigate this, we used
a CD3ζ mutant where all three ITAM sequences in CD3ζ were
modified by replacing the two key tyrosine residues in each ITAM
with leucine (CD3ζ–6YL) (Fig. 3A). The CD3ζ–6YL mutant was
fused to PSCFP2 and imaged in Jurkat–1G4 cells in which ex-
pression of endogenous CD3ζ was blocked with CRISPR/Cas9
gene editing. Jurkat–1G4 cells reconstituted with CD3ζ–6YL–
PSCFP2 were activated on antibody-coated slides (Fig. 3 B–E)
or pMHC-I–presenting bilayers (Fig. 3F). We confirmed that CD3ζ
could not be phosphorylated in cells expressing only the CD3ζ–6YL
mutant (Fig. 3B) and that pZap70 staining was minimal (Fig. 3C).
Cells expressing the CD3ζ–6YL mutant only did not spread on
the antibody-coated glass to the same extent as cells expressing
wild-type CD3ζ, indicating reduced T-cell activation (Fig. 3D).
However, CD3ζ clustering was similar to the wild-type CD3ζ: the
CD3ζ–6YL mutant formed denser clusters after T-cell activation
with either antibody-coated slides (Fig. 3E) or pMHC-containing
bilayers (Fig. 3F) and these CD3ζ–6YL nanoclusters had a
similar density than wild-type CD3ζ nanoclusters. Overall, these
results suggest that the reorganization of CD3ζ into dense clus-
ters upon TCR engagement was not dependent on the phos-
phorylation of CD3ζ. Thus, the formation of dense TCR–CD3
nanoclusters may precede CD3 phosphorylation.
Dense TCR–CD3 Clusters Are Signaling-Competent. In order for a
productive signal to be transmitted following ligand binding and
TCR–CD3 phosphorylation, downstream signaling molecules
such as Zap70 and Lat are recruited to phosphorylated TCR–
CD3 complexes and in turn phosphorylated (37). To test the
signaling competency of CD3ζ clusters, we examined the coloc-
alization of CD3ζ with phosphorylated Zap70 (pZap70) (Fig.
4A) and phosphorylated Lat (pLat) (Fig. 4B). Irrespective of
whether we compared noncolocalized clusters with colocalized
clusters (containing ≥10 CD3ζ molecules with a DoC score ≥
0.4) or nondense clusters with dense clusters (relative molecular
density >6), we found that CD3ζ clusters containing downstream
signaling molecules were dense and that dense clusters contained
more signaling proteins. Thus, the thresholds we defined did not
influence the outcome: the molecular density within clusters
determined the signaling competency of TCR–CD3 clusters.
We also examined the distribution of Lck and CD45 relative to
CD3ζ. Interestingly, although we found that pZap70 and pLat
had a large fraction of molecules colocalized with CD3ζ, rela-
tively few Lck molecules colocalized with CD3ζ (Fig. 4C), sug-
gesting that transient Lck–CD3ζ interactions may be sufficient to
initiate signaling at TCR signaling “hot spots” (26, 38). More
CD3ζ molecules colocalized with Lck at 5 min than at later time
points (Fig. 4D), supporting the notion that Lck may depart sig-
naling clusters following early recruitment, resulting in an overall
low level of colocalization as previously reported (39, 40). Fur-
thermore, although CD3ζ clusters contained pLat (Fig. 4B), our
imaging and analysis approach cannot discriminate between pLat
molecules in the plasma membrane and pLat molecules residing in
vesicles (25) that are adjacent to the plasma membrane.
CD45 molecules were partially segregated from CD3ζ mole-
cules, as judged by the low level of colocalization between CD45
and CD3ζ (Fig. 4C). The kinetic segregation model proposes
that CD45 exclusion initiates and sustains TCR signaling, be-
cause it shifts the balance of phosphatase and kinase activity in
favor of phosphorylation (41). When we investigated the relative
distribution of CD3ζ and CD45 at the nanoscale level, the per-
centage of CD45 molecules that colocalized with CD3ζ was
lower in activated cells than in resting cells, independent of the
type of stimulation (Fig. 5 A–C). Furthermore, in activated cells,
the small fraction of CD45 molecules that did colocalize with
CD3ζ molecules were found in nondense clusters and colocalized
clusters had a lower molecular density of CD3ζ than non-
colocalized clusters (Fig. 5 D and E). Together, these data support
Fig. 3. CD3ζ clustering occurs independently of phosphorylation. (A) Sche-
matic depicting the CD3ζ–6YL mutant in which the tyrosine (Y) residues con-
tained in the ITAM consensus sequences that have beenmutated to leucine (L).
The CD3ζ–6YL mutant no longer contains any phosphorylation sites. (B and
C) Confocal microscopy images of Jurkat–1G4 cells lacking endogenous
CD3ζ that were transfected to express wild-type CD3ζ (CD3ζ–WT) or the
CD3ζ–6YL mutant, on PLL or antibody-coated (αCD3+αCD28) glass surfaces
and immunostained for (B) pCD3ζ or (C) pZAP70. (Scale bars, 10 μm.) (D, Top)
Single-molecule images of CD3ζ–WT–PSCFP2 or CD3ζ–6YL–PSCFP2 in Jurkat–
1G4 cells on resting (PLL-coated) or antibody-coated (anti-CD3e and anti-
CD28 antibodies, αCD3+αCD28) glass surfaces. (Scale bars, 10 μm.) (Middle)
Cluster maps of representative regions (4 μm × 4 μm) highlighted in the single
molecule images (red boxes); where CD3ζ molecules in clusters are green and
molecules outside clusters are in blue. Cluster contours are highlighted with
red lines. (Bottom) Corresponding molecular density maps; normalized relative
density is pseudocolored according to the depicted scale. (E and F) Relative
density of CD3ζ–WT and CD3ζ–6YL in clusters for Jurkat-1G4 cells (E) on PLL- or
antibody-coated glass or (F) on bilayers containing ICAM-1 only or ICAM-1 and
high-affinity 9V–MHC-I. Data are mean ± SEM from 10 to 38 regions from 7 to
13 cells per condition; *P < 0.05; **P < 0.01 (ANOVA).



























that CD45 is excluded selectively from dense TCR–CD3 clusters,
possibly because of the large size of the CD45 ectodomain (41),
through charge repulsion (19) or through molecular crowding (42).
The Strength of pMHC–TCR Interaction Is Translated into Phosphorylation
Levels via the Density of TCR–CD3 Nanoclusters. Given that the
molecular density within clusters correlated with TCR–CD3
signaling efficiency, we investigated whether T cells used the
pMHC-I–induced formation of dense clusters for antigen dis-
crimination. If ligand binding drives TCR clustering, then ligand
affinity and dose should regulate this process. Altered peptide
ligands are antigenic peptides containing mutations in the TCR
contact site, giving rise to ligands with differences in affinity for
the TCR that correlate with downstream signaling potential (43).
We used a library of altered peptide ligands for the ILA1 TCR
(4) and examined the density of CD3ζ clusters (Fig. 6 A and B)
and T-cell activation (SI Appendix, Fig. S13 and S14) in response
to pMHC-I molecules with a range of binding affinities (KD =
>500–2.9 μM) at identical densities (∼400 molecules/μm2) (Fig.
6A and SI Appendix, Fig. S13) or with the same binding affinity
(KD = 2.9 μM) at different densities (40–4,000 molecules/μm2)
(Fig. 6B and SI Appendix, Fig. S14). Interestingly, calcium fluxes
could be detected in T cells on all bilayers containing pMHC-I
molecules (SI Appendix, Figs. S13 and S14), suggesting that calcium
fluxes may not require pMHC-induced changes in TCR–CD3
clustering. The fraction of cells displaying a dense ring of F-actin at
the synapse periphery, an indicator of cell spreading during acti-
vation, as well as the average cell area, both increased as a function
of pMHC-I affinity and dose, confirming that ligand affinity and
density affect the extent of downstream cellular outcomes.
We first characterized CD3ζ nanoclusters and found that the
molecular density within CD3ζ nanoclusters depended both on
pMHC-I affinity and concentration (Fig. 6 A and B). We con-
firmed that triggered CD3ζ clusters had a higher molecular
density than nontriggered clusters (Fig. 6C), which resulted in a
correlation between the molecular density within CD3ζ clusters
and the overall level of CD3ζ phosphorylation (Fig. 6D). Hence,
the ability of pMHC-I molecules to induce dense CD3ζ clusters
was found to be a function of pMHC–TCR affinity and dose and
correlated with the amount of signal generated. Given that CD3ζ
clustering was independent of CD3ζ phosphorylation (Fig. 3),
our data suggest that it is the formation of dense clusters that
translates pMHC–TCR interactions into intracellular signals.
To investigate whether TCR–CD3 clustering is a universal
mechanism for the translation of pMHC binding into signal ini-
tiation, we confirmed the finding in primary mouse OT-I CD8+
T cells on bilayers with various pMHC-I densities (Fig. 6E). Using
immunostaining to probe for TCR-β and pCD3ζ, we found that
the density of TCR-β nanoclusters depended on the pMHC-I
doses and that triggered clusters had a higher molecular density
than nontriggered clusters in primary T cells (Fig. 6F). Importantly,
the formation of dense clusters under the control of pMHC-I dose
strongly correlated with the overall amount of pCD3ζ (Fig. 6G).
Thus, TCR-β clustering translated pMHC-I dose into the amount
of local signal generated. Taken together, our data suggest that
pMHC-I–induced spatial reorganization of the TCR–CD3 complex
allows T cells to probe for and discriminate antigens.
Discussion
Although all TCR signaling begins with the phosphorylation of
the TCR–CD3 complex, how ligand binding to the TCR on the
extracellular side initiates phosphorylation of intracellular ITAM
domains on CD3 dimers remains a topic of intense debate (1, 2,
16). Combining a cluster detection (28) and colocalization (29)
Fig. 4. TCR clustering amplifies recruitment of downstream signaling molecules. (A and B, Left) Two-color single-molecule images and zoomed 4-μm × 4-μm
regions of (A) CD3ζ and pZap70 and (B) CD3ζ and pLat in Jurkat–ILA1 cells stimulated for 15 min on lipid bilayers presenting ICAM-1 (500 molecules/μm2) and
3G–MHC-I (400 molecules/μm2). (Scale bars, 10 μm.) (Middle) DoC maps of CD3ζ color-coded according to the DoC with pZap70 or pLat in representative 4-μm ×
4-μm regions. (Right) Relative density of CD3ζ molecules in colocalized and noncolocalized clusters with pZap70 or pLat. Colocalized clusters contained ≥10
CD3ζmolecules with a DoC score of ≥0.4. (Far Right) Percentage of CD3ζmolecules colocalized with pZap70 or pLat in dense and nondense CD3ζ clusters. *P <
0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 (paired t test). (C) Percentage of pZap70, CD45, pLat, and Lck molecules colocalized with CD3ζ. **P < 0.01
and ****P < 0.0001 (ANOVA). (D) Percentage of CD3ζ molecules colocalized with Lck in Jurkat–ILA1 cells stimulated on lipid bilayers presenting ICAM-1 (500
molecules/μm2) and 3G-MHC-I (400 molecules/μm2) for different durations (1, 5, 10, and 15 min). *P < 0.05 and ****P < 0.0001 (ANOVA).
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analysis for SMLM data, we demonstrated here that individual
TCR–CD3 complexes have different probabilities of being
phosphorylated depending on their proximity to neighboring
TCR complexes. Our finding places spatial organization at the
forefront of the regulation of TCR signaling. Taken together,
our data propose the following mechanistic insights of how TCR
signaling begins: pMHC–TCR interactions are first translated
into TCR–CD3 nanoclusters. The pMHC dose and affinity are
reflected in the molecular density within the clusters. Therefore,
in this first step, the antigen recognition event is converted into a
spatial pattern. The second step translates the spatial pattern:
that is, the density within the TCR–CD3 nanoclusters back into a
biochemical signature (i.e., the amount of TCR–CD3 phosphor-
ylation). This finding means that the overall signal generated
mirrors the binding characteristics of the pMHC–TCR interaction.
Given TCR diversity and MHC polymorphisms and therefore
the plethora of pMHC–TCR interactions (44), it is not surprising
that no common spatial arrangement of the TCR–CD3 complex
exists in resting or activated T cells. Thus, our data may reconcile
the seemingly contradictory reports of TCR–CD3 monomers
(45), functional dimers (46), clusters (47–49), and protein islands
(23). The diversity in TCR–CD3 nanocluster characteristics is,
however, intriguing. Remodeling of these clusters would allow
T cells to set activation thresholds (4), for example by pre-
clustering TCRs (48, 49) or restructuring cortical actin (50), to
enhance or prevent pMHC-induced clustering of TCRs.
A corollary of placing TCR–CD3 clustering after pMHC en-
gagement and before signal initiation is that signaling should
spontaneously begin in dense TCR–CD3 nanoclusters. This
finding is consistent with models, such as the kinetic segregation
model (41), which proposes that TCR signaling does not require the
activation of kinases (51) but only the exclusion of phosphatases,
such as CD45 from the TCR. Exclusion could be driven by the
large size of CD45 ectodomains that cannot be accommodated
within the limited space between the antigen-presenting cell
membrane and the T-cell membrane (41) or simply by charge
repulsion (19) or molecular crowding (42). Indeed, we observed
a selective reduction of CD45 in dense TCR–CD3 nanoclusters
but found no evidence for the recruitment of Lck to these
clusters. Whether shifting the balance of phosphatases to kinases
within and around nanoclusters is sufficient remains to be seen.
A striking feature in our data is that the molecular density
within TCR–CD3 correlated with signaling efficiency. The av-
erage spacing between CD3ζ molecules decreased from 17 nm in
nontriggered clusters to 10 nm in triggered clusters. It is thus
possible that there is cooperativity between TCRs in clusters, either
through transmission of conformational changes to neighboring
Fig. 5. CD45 is excluded from CD3ζ clusters in activated T cells. (A) Two-
color single-molecule map (4 μm × 4 μm) of CD3ζ and CD45 in Jurkat–ILA1
cells on antibody-coated (αCD3+αCD28) glass surface (Upper) and corre-
sponding DoC map, where CD3ζ molecules are color-coded according to
their DoC score (Lower). (B and C) Percentage of CD45 molecules colocalized
with CD3ζ in Jurkat–ILA1 cells on resting (PLL-coated) or antibody-coated
(anti-CD3e and anti-CD28 antibodies, αCD3+αCD28) glass surfaces (B, 10 min)
and on supported lipid bilayers (C, 15 min) containing ICAM-1 (500 mole-
cules/μm2) and low-affinity 8T–MHC-I (400 molecules/μm2) or ICAM-1 and
high-affinity 3G–MHC-I (400 molecules/μm2). Data are mean ± SEM from 11
to 44 regions from 4 to 10 cells per condition; **P < 0.01 and ***P < 0.001
(unpaired t test). (D) Relative density of CD3ζ molecules in colocalized and
noncolocalized clusters with CD45. Colocalized clusters contained ≥10 CD3ζ
molecules with a DoC score of ≥0.4. (E) Percentage of CD3ζ molecules
colocalized with CD45 in dense and nondense clusters. In (D and E), data are
mean ± SEM from 44 regions from 10 cells; *P < 0.05 and ***P < 0.001
(paired t test).
Fig. 6. TCR triggering efficiency as a function of pMHC affinity and concen-
tration. (A and B) Relative density of CD3ζ molecules in clusters in Jurkat–ILA1
cells on lipid bilayers (15 min) presenting (A) ICAM-1 (500 molecules/μm2) and
pMHC-I (400 molecules/μm2) of different affinities (KD ranging from >500 μM
to 2.9 μM) or (B) ICAM-1 (500molecules/μm2) and high-affinity 3G–MHC-I (KD =
2.9 μM) at different concentrations (40–4,000 molecules/μm2). Data are mean ±
SEM from 6 to 30 regions from 3 to 11 cells per condition. *P < 0.05, ***P <
0.001, and ****P < 0.0001 (one-way ANOVA). (C) Relative density of CD3ζ
molecules in triggered and nontriggered clusters in Jurkat–ILA1 cells on
bilayers with 3G–MHC-I (KD = 2.9 μM) at 40, 400, and 4,000 molecules/μm2 and
8T–MHC-I (KD= 24 μM) at 400molecules/μm2. (D) Number of pCD3ζmolecules/μm2
detected in Jurkat–ILA1 cells stimulated as in C as a function of the relative
density of CD3ζ in clusters. In C and D, data are mean ± SEM from at least
nine regions from three cells per condition. *P < 0.05, **P < 0.01, and ***P <
0.001 (paired t test for C). (E) TIRF images of TCR-β (green) and pCD3ζ (red) in
primary mouse OT-I CD8+ T cells stimulated for 10 min on lipid bilayers with
ICAM-1 (500 molecules/μm2), B7.1 and different OVA–MHC-I densities (20,
200, or 2,000 molecules/μm2). (Scale bars, 10 μm.) (F) Relative density of TCR-
β molecules in triggered and nontriggered clusters in primary mouse OT-I
CD8+ T cells stimulated as in E and imaged by two-color dSTORM. (G)
Number of pCD3ζ molecules/μm2 for conditions shown in F as a function of
the relative density of CD3ζ in clusters. For F and G, data are mean ± SEM
from 7 to 10 regions from 4 to 5 cells per condition. *P < 0.05 and ***P <
0.001 (paired t test for F).



























TCRs (52) or through increased localized phosphorylation of
TCRs by clustered Lck (26, 27). Signaling efficiency in dense
clusters may also be augmented by the detachment of the ITAM-
containing cytoplasmic domains of CD3ζ (53) and CD3e (54)
from the membrane so that they are accessible to Lck for
phosphorylation. This so-called safety-lock mechanism of TCR
signaling could be overcome in densely packed nanoclusters.
Similarly, the stabilizing influence of neighboring TCRs could
effectively prolong TCR–pMHC-I interactions (48, 55) and the
immobilization of clustered TCRs (23) could enable multiple
rounds of rebinding (56) and serial engagements (57, 58). All of
these processes including CD45 exclusion could contribute to the
enhanced signaling competency of densely packed TCR–CD3
nanoclusters.
Our data demonstrated that CD3ζ clustering upon antibody
and pMHC stimulation did not require CD3ζ phosphorylation,
strongly suggesting that clustering precedes phosphorylation. In
agreement with the notion that clustering drives signaling, rather
than phosphorylation leading to clustering, artificial clustering of
CD3ζ using a chemically inducible system resulted in strong
TCR–CD3 phosphorylation under physiological levels of Lck
and CD45 (59). Taking these data together, we find that it is in-
deed possible that signaling begins spontaneously in dense TCR–
CD3 clusters.
Why would an intermediate step between pMHC engagement
and signal initiation be beneficial to T cells? To explain how
TCR triggering accounts for the selectivity, specificity and speed
of the T-cell response (1), mathematical models have linked
“input” (e.g., pMHC dose and TCR–pMHC affinity) to “output”
(e.g., signaling and cytokine secretion) (60). The kinetic proof-
reading model (61), for example, proposed that the TCR needs
to undergo a series of intermediate steps before being triggered
so that the overall response depends on the TCR–pMHC dis-
sociation time. Other models propose an optimal dwell time for
TCR–pMHC interactions (62) or serial engagement of different
TCRs by the same pMHC (57, 63). In all of these models, the
intermediate steps are necessary for antigen discrimination. We
propose here that the pMHC-induced formation of TCR–CD3
nanoclusters is the intermediate step that allows T cells to distin-
guish both pMHC binding affinity and dose. Spatial reorganiza-
tion could explain how structurally and biophysically diverse
TCR–pMHC interactions result in a common TCR triggering
mechanism.
The mechanisms underlying the formation, regulation, and
reorganization of TCR nanoclusters remain unclear and repre-
sent a major area of interest for future research. Previous studies
have suggested that the actin cytoskeleton might be involved in
the formation of TCR microclusters (39) and in the regulation of
T-cell signaling clusters (19). In resting cells, the nonrandom
distribution of the TCR may be maintained by cytoskeleton-
based partitioning of the membrane into domains (64). TCR/
pMHC binding occurs in regions of close contact and the in-
creased TCR cluster density observed in activated T cells may
represent the consolidation of these close contact regions driven
by minimization of membrane bending energy (42). Another
possibility is that pulling induces a conformational change in the
structure of the TCR–CD3 complex that would favor the clus-
tering of engaged TCR–CD3 complexes with other unengaged
TCR–CD3 complexes. There is mounting evidence that me-
chanical forces are at play in the processes of TCR triggering and
antigen discrimination (1, 65), but other mechanisms may also
be involved.
In conclusion, the TCR–CD3 complex is not an autonomous
signaling unit. Instead, TCR triggering efficiency is dictated by
the spacing to neighboring TCR–CD3 complexes. Furthermore,
the coupling of ligand binding to signal initiation via spatial re-
organization is a process that enables antigen discrimination.
Ligand-induced, nanoscale reorganization may also regulate the
signaling efficiencies of other receptor systems and our study
provides an experimental and conceptual framework that links
spatial organization of individual molecules to their biochemical
activity.
Methods
Cell Lines, pMHC Monomers, and Recombinant Proteins. Jurkat T cells (Clone
E6.1, ATCC) and other Jurkat-derived cell lines were maintained in RPMI 1640
(Gibco) supplemented with 10% (vol/vol) FCS, 2 mM L-glutamine, and 1 mM
penicillin and streptomycin (all from Invitrogen). Cells were transfected by
electroporation (NEON; Invitrogen) to express CD3ζ fused to PSCFP2. PSCFP2
expression construct was from Evrogen.
The ILA1 TCR recognizes residues 540–548 (ILAKFLHWL, abbreviated as
ILA) of the human telomerase reverse-transcriptase protein, presented in the
context of the human MHC class I HLA-A*0201 (HLA-A2). Jurkat cells stably
expressing the ILA1 TCR (called Jurkat–ILA1 hereafter), as well as monomeric
human HLA-A2 complexed with the ILA peptide and several altered peptides
(3G, 8T, 5Y, 8E) were used in this study. These peptide ligands have been
characterized previously (31, 66, 67). Their KD values are as follows: 3G (2.9 μM),
8T (24 μM), ILA (32 μM), 5Y (250 μM), and 8E (>500 μM).
The 1G4 TCR recognizes the SLLMWITQCpeptide presented byHLA-A2 (32,
68). TCR-deficient Jurkat-76 cells were engineered to stably express the 1G4
TCR, and endogenous CD3ζ was knocked out or fused to PSCFP2 by CRISPR/
Cas9 technology. Biotinylated pMHC monomers of different affinities were
used: 4D (KD = 252 μM), 6V (KD = 18 μM), and 9V (KD = 7.2 μM).
Jurkat-76 cells stably expressing OT-I TCR (called Jurkat–OT-I hereafter)
were generated by retroviral transduction. For this, the packaging cell line
Phoenix amphotropic (Nolan Laboratory, Stanford University, Stanford, CA)
was transfected with Lipofectamine LTX (Invitrogen) with the retroviral
plasmid encoding OT-I TCR (TCRa-V2 and TCRb-V5), a gift from Ian Parish,
Australian National University, Canberra, ACT, Australia. Viral supernatant
collected 24 and 48 h after transfection was used for infection of Jurkat-76
cells. One week after infection, cells expressing OT-I were enriched by flow
cytometry. Monomeric mouse H-2Kb complexed with the ovalbumin-derived
peptide SIINFEKL (amino acids 257–264) was synthesized at the Australian
Cancer Research Foundation Biomolecular Resource Facility at The John
Curtin School of Medical Research, Australian National University, using BirA
enzyme synthesized as described previously (69). This pMHC was synthesized
with a carboxyl-terminal biotin-tag at the α-chain for incorporation on
lipid bilayers.
Soluble ICAM-1 recombinant protein with a C-terminal His-tag was pro-
duced from stably transfected Schneider cells (S2). Protein production in S2
cells was induced using 0.5 mM CuSO4 for 5 d. The supernatant containing
ICAM-1 was collected by centrifugation, then filtered and dialyzed against
PBS plus 1 mM EDTA and then PBS only to remove CuSO4. ICAM-1 was pu-
rified using a 5 mL NiNTA column. His-tagged CD80 recombinant mouse
protein (B7.1) was purchased from Life Technologies (50446-M08H-50).
Monomeric biotinylated pMHCs and recombinant proteins were stored at
−80 °C. Stock dilutions were stored at 4 °C and used for several experiments.
Generation of CD3ζ–6YL Mutant. The CD3ζ–ITAM Tyr to Leu mutant (CD3ζ
−6YL) was generated by consecutive site-directed mutagenesis using the
appropriate primer pairs. Mutagenesis at the correct sites was verified by
Sanger sequencing.
Primary Mouse OT-I CD8+ T Cells. All primary T-cell experiments were ap-
proved by the University of New South Wales Animal Care and Ethics
Committee. OT-I transgenic mice were bred at Australian BioResources Pty
Ltd and were allowed to acclimatize for one week on arrival at the University
of New South Wales under specific pathogen-free conditions with a 12-h
light/12-h dark cycle before being killed for any experiments.
A single-cell suspension was created by passing a freshly excised spleen
through a 40-μm cell strainer (BD Biosciences). Splenocytes were then
centrifuged for 5 min at 300 × g and resuspended in 1 mL of red blood cell
lysing buffer (Sigma) with gentle mixing for 1 min. Splenocytes were then
diluted with 15 mL of PBS, again centrifuged, and resuspended in 10 mL of
complete RPMI-1640 culture medium [10% (vol/vol) FBS, 2 mM L-glutamine,
100 μg/mL penicillin and streptomycin, 1 mM sodium pyruvate, 0.1 mM MEM
nonessential amino acids, and 0.05 mM 2-Mercaptoethanol]. Cells were then
filtered through a 40-μm cell strainer, a viable cell count performed, and 20 ×
106 cells cultured in a 75-cm2 flask in complete RPMI-1640 for 4 d in the
presence of 1 μg OVA257–264 (SIINFEKL) peptide (Invivogen), 10 U/mL
recombinant murine IL-2 (Peprotech), and 0.03 μg/mL lipopolysaccharides from
Escherichia coli (0111:B4, Sigma). On day 4, the purity of the preparation was
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analyzed by flow cytometry and the cytotoxic T lymphocytes harvested for
imaging experiments.
Bilayer Preparation. Glass coverslips (Lab-Tek chambers, 155411, Nunc) were
cleaned with 10 M NaOH for 15 min followed by 5 min in 70% (vol/vol)
ethanol, then rinsed thoroughly with MilliQ water. A liposome solution of
1 mg/mL with a lipid ratio of 96.5% DOPC, 2% DGS-NTA(Ni), 1% Biotinyl-cap-
PE, and 0.5% PEG5,000-PE (mol%; all fromAvanti Polar Lipids) was created by
vesicle extrusion, as described in detail elsewhere (70). Wells were incubated
with liposomes at 0.2 mg/mL for 30 min at room temperature, washed with
excess PBS, and blocked with 1% BSA in PBS for 30 min at room tempera-
ture. For addition of proteins, bilayers were incubated with 2 μg/mL strep-
tavidin (Sigma) for 10 min at room temperature, then washed thoroughly
before adding (biotinylated) pMHC (2.5–500 ng/mL) and (His-tagged) ICAM-
1 (200 ng/mL) for 100 min at room temperature and thoroughly washing off
any excess unbound protein with PBS. Bilayers were loaded with pMHC at a
density of 400 molecules/μm2, unless described otherwise. For experiments
with primary mouse cells, the bilayers were also loaded with His-tagged
B7.1/CD80 (500 ng/mL). The fluidity of lipids (using rhodamine-labeled DOPE)
and proteins (using fluorescent streptavidin) in supported lipid bilayers was
assessed by fluorescence recovery after photobleaching (FRAP) on a confocal
fluorescencemicroscope (Fluoview FV1000, Olympus) with a 100× oil-immersion
objective with a numerical aperture (NA) of 1.4. The concentration of pMHC
on the bilayers was determined by fluorescence correlation spectroscopy
(FCS) on a confocal fluorescence microscope (MicroTime200, PicoQuant) with
a 100× water-immersion objective with 1.25 NA.
Sample Preparation. For imaging of resting cells, cellswere incubated for 10min
at 37 °C on glass surfaces coated with PLL, prepared by incubation of glass
coverslips for 30 min at room temperature with 0.01% (wt/vol) PLL (Sigma). For
activating cells on glass, cells were allowed to settle on coverslips coated with
anti-CD3e (16-0037; eBioscience) and anti-CD28 (16-0289; eBioscience) for
10 min at 37 °C. Antibodies were adsorbed onto surfaces by incubation of
clean glass coverslips with antibody (10-μg/mL each) for at least 1 h at 37 °C.
For stimulating cells on lipid bilayers, cells were allowed to settle on bilayers
for 10 or 15 mins at 37 °C. Cells were fixed with 4% paraformaldehyde (vol/vol)
in PBS for 20 min at room temperature.
For immunostaining, cells were labeled with primary antibody followed by
DyLight649- or Alexa Fluor647-conjugated goat antibody specific to the
rabbit F(ab′)2 fragment [111-495-047 (discontinued) and 111–606-047; Jackson
ImmunoResearch]. Primary antibodies used in this study were against human
CD3ζ phosphorylated at Tyr142 either unconjugated (ab68235; Abcam) or
directly conjugated to Alexa Fluor647 (558489, BD Biosciences), CD45
(ab10559; Abcam), Lat phosphorylated at Tyr171 (3581S, Cell Signaling),
Zap70 phosphorylated at Tyr319 (2701S, Cell Signaling), or Lck (sc-433, Santa
Cruz Biotechnology). For experiments with primary mouse cells, an antibody
against mouse TCR-β directly conjugated to Alexa Fluor488 or Alexa
Fluor647 (H57-597; 109215 and 109218, Biolegend) was used. After fixation,
cells were permeabilized with 0.1% (vol/vol) Triton X-100 for 4 min at room
temperature, blocked in 5% BSA (wt/vol) in PBS, and probed for 1 h at room
temperature with primary and secondary antibodies sequentially. An oxy-
gen-scavenging PBS-based buffer (containing 25 mM Hepes, 25 mM glucose,
5% (vol/vol) glycerol, 0.05 mg/mL glucose oxidase, and 0.025 mg/mL horse-
radish peroxidase, supplemented with 50 mM cysteamine; all from Sigma)
was used for dSTORM imaging.
Imaging Calcium Fluxes and Actin Polymerization. For imaging calcium fluxes
and actin polymerization in response to different conditions, cells were
imaged by confocal microscopy using an SP5 inverted confocal microscope
(TCS SP5 WLL STED; Leica Microsystems) using a 20× or 63× water-immersion
objective (NA = 1.2). For visualization of calcium fluxes, cells were treated
with 5 μM Fluo-4-AM (Life Technologies) for 1 h at room temperature. Cells
were washed twice and resuspended in HBSS, then imaged live as they were
landing on bilayers. For imaging actin polymerization, cells were stained
with phalloidin conjugated to Alexa Fluor488 (Life Technologies) for 1 h at
room temperature. For both Fluo-4-AM and phalloidin-AF488, the fluores-
cence signal was visualized using the 488-nm laser line (fluorescence was
collected between 500 and 575 nm). Data analysis and processing were
performed using ImageJ software (National Institutes of Health). For analysis
of calcium flux data, the number of responding cells was quantified and the
“cell activation time” (i.e., the duration between the cell landing on the
surface and the increase in Fluo-4-AM signal) was measured for cells in which
a calcium flux was detected. For analysis of cell spreading, the number of
spread cells was quantified and the cell area was measured for all cells based
on a thresholded image of the phalloidin staining. Spreading of cells was
defined by the presence of a polymerized “actin ring” (i.e., a broad ring of
intense F-actin staining surrounding an unstained cell center).
Single-Molecule Localization Microscopy. PALM and dSTORM image sequences
were acquired on a total internal reflection fluorescence (TIRF) microscope
(ELYRA, Zeiss) with a 100× oil-immersion objective (NA = 1.46). Photo-
conversion of PSCFP2 was achieved with 8 μW of 405-nm laser radiation and
the green-converted PSCFP2 was imaged with 18 mW of 488-nm light. For
DyLight649/Alexa Fluor647 dSTORM, 15 mW of 633-nm laser illumination
was used for imaging, with 0.1–1 mW of 488 nm for conversion from the
dark state. For PALM and dSTORM, 20,000 images were acquired per sample
with a cooled, electron-multiplying charge-coupled device camera (iXon DU-
897; Andor) with an exposure time of 30 ms. For two-color acquisitions, the
DyLight649/Alexa Fluor647 channel was acquired first, followed by PSCFP2.
Raw fluorescence intensity images were analyzed with the software Zen
2011 SP3 (Zeiss MicroImaging), generating tables containing the x-y particle
coordinates of each molecule detected in the acquisition.
Cluster Analysis of One-Color Data. SMLM data were analyzed using custom
software written in MATLAB (MathWorks) for detection of clusters and ex-
traction of clustering parameters. Typically, for each cell one to five non-
overlapping representative regions of 4 × 4 μm2 were selected for analysis.
First we used Ripley’s K function (71) to determine the extent of clustering
of a population of molecules compared with a randomly distributed set of
molecules. This amount was calculated using SpPack, an add-in for Microsoft
Excel (72), as well as a customMATLAB version optimized for larger datasets.
In short, the Ripley’s K function calculates for each molecule the number of
neighbor molecules within a given radius r corrected by the total density;
finally, for each radius the average is calculated over all molecules. The
Ripley’s K function provides ensemble information on the whole region of
interest; it provides information on the level of clustering of molecules in a
region. However no analysis is performed at the cluster level and therefore
no information is available on individual clusters.
To retrieve information on individual clusters, we used DBSCAN analysis (28)
to identify individual clusters. The DBSCAN method detects clusters using a
propagative method which links points belonging to the same cluster based
on two parameters; the minimum number of neighbors e (e = 3) in the radius r
(r = 20 nm). The DBSCAN routine was implemented in MATLAB and sub-
sequently coded in c++ and compiled in a MEX file (Matlab executable file) to
improve the speed of processing as we are working with large data files.
Two-Color Colocalization Analysis. The two-color data were analyzed using a
modified version of the coordinate-based colocalization method (29). The
first step in the analysis is to remove molecules which are isolated, by ex-
cluding points with a local density below a random distribution (total den-
sity = total number of molecules/total area of region of interest). This is
important to reduce the size of the dataset because the subsequent steps
are highly computationally demanding. In addition, these outlier molecules
do not contribute to the clusters and would anyway get excluded in the
DBSCAN step.
Then, for each molecule, the local density of each channel is calculated at
increasing radius size (10–500 nm), providing the density gradient around
that molecule for each channel. The two density gradients are tested for
correlation with the Spearman criteria, which score monotonic dependence.
This parameter of correlation is corrected with nearest-neighbor distance to
account for long distance interactions. As a result, each molecule is scored
with this parameter, indicating the DoC, ranging from −1 to 1, with −1
characterizing anticolocalization (or segregation), 0 corresponding to single
species, and 1 defining high colocalization. The method favors molecules in
clusters compared with randomly distributed molecules. SI Appendix, Fig. S9
shows that paired randomly distributed molecules score a lower DoC than
clustered molecules independently for paired and unpaired.
From the local density of each molecule taken at a radius of 20 nm and
normalized to the total density of the region, a pseudomap is created in
which each molecule is represented with a color code corresponding to the
normalized density. In a similar way, a map showing the DoC for each
molecule is created. These maps enable us to visualize the morphology of the
clusters and their organization. The threshold value of 0.4 was determined
from simulations to discriminate colocalized from noncolocalized molecules.
In the next step, we detect the individual clusters using a DBSCAN analysis,
similarly to the one-color analysis. The clusters are subsequently separated
into colocalized clusters (containing more than 10molecules with a DoC score
above 0.4) and noncolocalized clusters. These two populations of clusters are
then analyzed to extract their density, size, circularity, and any other type
of information.



























Statistical Analysis. All statistical analysis was performed using GraphPad
software (Prism). Statistical significance between datasets was determined
by performing two-tailed, unpaired Student’s t tests. For comparing trig-
gered and nontriggered or colocalized and noncolocalized clusters, a paired
Student’s t test was used. Multiple means were compared with one-way
ANOVA and Tukey’s multiple comparisons test. Graphs show mean values,
and error bars represent the SEM. In statistical analysis, P > 0.05 is in-
dicated as not significant (n.s.), whereas statistically significant values
are indicated by asterisks as follows: *P ≤ 0.05, **P < 0.01, ***P < 0.001,
and ****P < 0.0001.
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